Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery
- First Posted Date
- 2015-01-01
- Last Posted Date
- 2019-02-20
- Lead Sponsor
- A.T. Resolve SARL
- Target Recruit Count
- 256
- Registration Number
- NCT02329743
- Locations
- 🇺🇸
Auven Therapeutics, Murray Hill, New Jersey, United States
News
No news found